Cash Flow SCHOTT Pharma AG & Co. KGaA Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Sep'24
Dec'23
Sep'23
Dec'22
Sep'22
Sep'21
No of Months
12
12
12
12
12
12
Profit Before Tax
171.00
0.00
174.00
0.00
145.00
109.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
12.00
0.00
-14.00
0.00
-24.00
-15.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
225.00
0.00
181.00
0.00
182.00
134.00
Cash Flow from Investing Activities
-145.00
0.00
-171.00
0.00
-142.00
-98.00
Cash Flow from Financing Activities
-78.00
0.00
-11.00
0.00
-42.00
-27.00
Net Cash Inflow / Outflow
-1.00
0.00
-4.00
0.00
0.00
9.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-2.00
0.00
-3.00
0.00
3.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in EUR Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of SCHOTT Pharma AG & Co. KGaA
Figures in Million
No Consolidated Results Declared by Selected Peer
Cash Flow - Snapshot (Consolidated) - Sep'24
YoY Growth in year ended Sep 2024 is 24.04% vs NA in Sep 2023
Sep'24
Sep'23
Change(%)
Cash Flow from Operating Activities
225.33
181.65
24.04%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
